Published • loading... • Updated
Inside the Laboratory Working on a Hantavirus Vaccine
University of Bath researchers say the antigen targets Hantaan disease as they work toward a vaccine against hantavirus spread by rodents.
- Scientists from the University of Bath have developed a new antigen against Hantaan disease, a type of hantavirus, offering potential for a vaccine against the virus.
- Hantaviruses are typically spread to humans through exposure to infected rodents, particularly via their droppings, saliva, or urine, yet no effective vaccine or specific antiviral treatment currently exists.
- EnsiliTech, a Bristol-based startup, is collaborating with researchers to eliminate cold-storage requirements for vaccine distribution, potentially revolutionizing transportation and administration globally.
- The antigen successfully elicited a strong immune response, though researchers noted further work is required before market deployment of this novel hantavirus approach.
- Future scaling efforts aim to reach populations most vulnerable to Hantaan disease, positioning this innovation to provide protection for large at-risk groups worldwide.
Insights by Ground AI
34 Articles
34 Articles
ABC FOX Montana+31 Reposted by 31 other sources
Inside the laboratory working on a hantavirus vaccine
A team of scientists from the University of Bath have developed a new antigen against the Hantaan disease - a type of hantavirus
·Missoula, United States
Read Full Article
Coverage Details
Total News Sources34
Leaning Left6Leaning Right5Center10Last UpdatedBias Distribution48% Center
Bias Distribution
- 48% of the sources are Center
48% Center
L 28%
C 48%
R 24%
Factuality
To view factuality data please Upgrade to Premium
